News & Events

News & Events

Latest

Biostatistics Information sessions for graduate program admissions. Finger pressing button
Biostatistics Information sessions for graduate program admissions. Finger pressing button
Admissions information sessions for UW biostatistics graduate programs
Information sessions will be held via Zoom and led by our admissions manager. Each session will review the degree program's focus, format, curriculum, research opportunities, hands-on work experience, post-degree job outlook, admissions requirements, application process, and more.
Overview of UW Biostatistics and Statistics mixer at Joint Statistical Meeting held in Portland Oregon 2024
Overview of UW Biostatistics and Statistics mixer at Joint Statistical Meeting held in Portland Oregon 2024
Student presentations, awards, and alumni reception at JSM
The University of Washington Biostatistics Department was well-represented at this year’s Joint Statistical Meetings (JSM), with faculty and students receiving awards both during and prior to the conference. Community members also had the chance to connect with colleagues at the annual UW Biostatistics/Statistics reception.
Kat Hoffman
Kat Hoffman
Kat Hoffman awarded Gertrude M. Cox Scholarship
Kat Hoffman awarded ASA's Gertrude M. Cox Scholarship recognizing Hoffman’s methodological research developing machine-learning based methods drawing on causal inference on longitudinal interventions.
Jennifer Bobb
Jennifer Bobb
Jennifer Bobb receives prestigious COPSS Emerging Leader Award
Affiliate Associate Professor of Biostatistics Jennifer Bobb was recognized by the Committee of Presidents of Statistical Societies (COPSS) as an emerging leader for her significant methodological and applied contributions to the field of environmental biostatistics.
Photo of man pointing thumbs down
Photo of man pointing thumbs down
HIV Vaccine Candidates Fail to Reduce Infections
Precision Vaccinations,

Dr. Peter Gilbert shares insights about his work with HIV vaccine efficacy trials in relation to the recent PrEPVacc study. Gilbert said, "The result was that, for each vaccine, there is close to a 50-50 chance that the vaccine elevated acquisition risk vs. the vaccine was safe, as a synthesis of results over multiple ways to do the analysis, most importantly considering different prior distributions for vaccine efficacy."